168 related articles for article (PubMed ID: 14574328)
1. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions.
Tiscornia AC; Cayota A; Landoni AI; Brito C; Oppezzo P; Vuillier F; Robello C; Dighiero G; Gabús R; Pritsch O
Leukemia; 2004 Jan; 18(1):48-56. PubMed ID: 14574328
[TBL] [Abstract][Full Text] [Related]
2. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
[TBL] [Abstract][Full Text] [Related]
3. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity.
Zhao H; Dugas N; Mathiot C; Delmer A; Dugas B; Sigaux F; Kolb JP
Blood; 1998 Aug; 92(3):1031-43. PubMed ID: 9680373
[TBL] [Abstract][Full Text] [Related]
4. Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia.
Billard C; Kern C; Tang R; Ajchenbaum-Cymbalista F; Kolb JP
Leukemia; 2003 Dec; 17(12):2435-43. PubMed ID: 14523476
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of inducible nitric oxide synthase.
Kleinert H; Schwarz PM; Förstermann U
Biol Chem; 2003; 384(10-11):1343-64. PubMed ID: 14669979
[TBL] [Abstract][Full Text] [Related]
6. [Nitric oxide in supernatants of leukocytes and the serum of patients with B-CLL].
Jabłońska E; Kiersnowska-Rogowska B; Puzewska W; Rogowski F; Parfieńczyk A
Przegl Lek; 2006; 63(12):1286-90. PubMed ID: 17642141
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the expression of inducible nitric oxide synthase.
Kleinert H; Pautz A; Linker K; Schwarz PM
Eur J Pharmacol; 2004 Oct; 500(1-3):255-66. PubMed ID: 15464038
[TBL] [Abstract][Full Text] [Related]
8. Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent.
Billard C; Menasria F; Quiney C; Faussat AM; Kolb JP
Leuk Res; 2008 May; 32(5):755-60. PubMed ID: 17981326
[TBL] [Abstract][Full Text] [Related]
9. Expression and transcriptional regulation of functionally distinct Bmf isoforms in B-chronic lymphocytic leukemia cells.
Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
Leukemia; 2004 Jan; 18(1):41-7. PubMed ID: 14574334
[TBL] [Abstract][Full Text] [Related]
10. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells.
Binder C; Schulz M; Hiddemann W; Oellerich M
Lab Invest; 1999 Dec; 79(12):1703-12. PubMed ID: 10616218
[TBL] [Abstract][Full Text] [Related]
11. Antiapoptotic role of endogenous nitric oxide in human melanoma cells.
Salvucci O; Carsana M; Bersani I; Tragni G; Anichini A
Cancer Res; 2001 Jan; 61(1):318-26. PubMed ID: 11196180
[TBL] [Abstract][Full Text] [Related]
12. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine.
Carew JS; Nawrocki ST; Xu RH; Dunner K; McConkey DJ; Wierda WG; Keating MJ; Huang P
Leukemia; 2004 Dec; 18(12):1934-40. PubMed ID: 15483672
[TBL] [Abstract][Full Text] [Related]
13. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase in the liver: regulation and function.
Taylor BS; Alarcon LH; Billiar TR
Biochemistry (Mosc); 1998 Jul; 63(7):766-81. PubMed ID: 9721329
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1beta and cAMP in rat mesangial cells.
Eberhardt W; Plüss C; Hummel R; Pfeilschifter J
J Immunol; 1998 May; 160(10):4961-9. PubMed ID: 9590244
[TBL] [Abstract][Full Text] [Related]
16. Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells.
Quiney C; Dauzonne D; Kern C; Fourneron JD; Izard JC; Mohammad RM; Kolb JP; Billard C
Leuk Res; 2004 Aug; 28(8):851-61. PubMed ID: 15203283
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.
Levesque MC; Chen Y; Beasley BE; O'Loughlin CW; Gockerman JP; Moore JO; Weinberg JB
Leuk Res; 2006 Jan; 30(1):24-8. PubMed ID: 16039714
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
